An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

Ghanaian-born researcher David U. Mualen, a PhD candidate in Biomedical Engineering in the United States, is gaining international recognition for research that is reshaping how modern medicines are ...

Patients with pre-existing high blood pressure are more likely to be susceptible to heart damage caused by anthracyclines, the most widely used chemotherapy drugs for cancer treatment for more than 30 ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, offering hope for difficult AML cases.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...